vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and HERITAGE COMMERCE CORP (HTBK). Click either name above to swap in a different company.

Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $53.6M, roughly 1.2× HERITAGE COMMERCE CORP). HERITAGE COMMERCE CORP runs the higher net margin — 28.2% vs -70.9%, a 99.1% gap on every dollar of revenue. On growth, HERITAGE COMMERCE CORP posted the faster year-over-year revenue change (15.6% vs 8.1%). HERITAGE COMMERCE CORP produced more free cash flow last quarter ($61.3M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 12.8%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

The United States Chamber of Commerce (USCC) is a business association advocacy group and is the largest lobbying group in the United States. The group was founded in April 23, 1912, out of local chambers of commerce at the urging of President William Howard Taft and his secretary of commerce and labor Charles Nagel. President Taft's belief was that the "government needed to deal with a group that could speak with authority for the interests of business."

CTKB vs HTBK — Head-to-Head

Bigger by revenue
CTKB
CTKB
1.2× larger
CTKB
$62.1M
$53.6M
HTBK
Growing faster (revenue YoY)
HTBK
HTBK
+7.5% gap
HTBK
15.6%
8.1%
CTKB
Higher net margin
HTBK
HTBK
99.1% more per $
HTBK
28.2%
-70.9%
CTKB
More free cash flow
HTBK
HTBK
$63.1M more FCF
HTBK
$61.3M
$-1.8M
CTKB
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
12.8%
HTBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
HTBK
HTBK
Revenue
$62.1M
$53.6M
Net Profit
$-44.1M
$15.1M
Gross Margin
52.9%
Operating Margin
-9.0%
41.0%
Net Margin
-70.9%
28.2%
Revenue YoY
8.1%
15.6%
Net Profit YoY
-557.1%
42.3%
EPS (diluted)
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
HTBK
HTBK
Q4 25
$62.1M
$53.6M
Q3 25
$52.3M
$50.0M
Q2 25
$45.6M
$47.8M
Q1 25
$41.5M
$46.1M
Q4 24
$57.5M
$46.4M
Q3 24
$51.5M
$42.2M
Q2 24
$46.6M
$41.7M
Q1 24
$44.9M
$42.1M
Net Profit
CTKB
CTKB
HTBK
HTBK
Q4 25
$-44.1M
$15.1M
Q3 25
$-5.5M
$14.7M
Q2 25
$-5.6M
$6.4M
Q1 25
$-11.4M
$11.6M
Q4 24
$9.6M
$10.6M
Q3 24
$941.0K
$10.5M
Q2 24
$-10.4M
$9.2M
Q1 24
$-6.2M
$10.2M
Gross Margin
CTKB
CTKB
HTBK
HTBK
Q4 25
52.9%
Q3 25
52.7%
Q2 25
52.3%
Q1 25
48.6%
Q4 24
58.5%
Q3 24
56.3%
Q2 24
54.6%
Q1 24
51.3%
Operating Margin
CTKB
CTKB
HTBK
HTBK
Q4 25
-9.0%
41.0%
Q3 25
-17.6%
41.1%
Q2 25
-23.3%
18.7%
Q1 25
-36.1%
35.4%
Q4 24
5.2%
31.8%
Q3 24
-8.2%
34.3%
Q2 24
-18.3%
31.3%
Q1 24
-23.9%
34.2%
Net Margin
CTKB
CTKB
HTBK
HTBK
Q4 25
-70.9%
28.2%
Q3 25
-10.5%
29.4%
Q2 25
-12.2%
13.4%
Q1 25
-27.5%
25.2%
Q4 24
16.8%
22.9%
Q3 24
1.8%
24.9%
Q2 24
-22.4%
22.1%
Q1 24
-13.8%
24.1%
EPS (diluted)
CTKB
CTKB
HTBK
HTBK
Q4 25
$0.25
Q3 25
$0.24
Q2 25
$0.10
Q1 25
$0.19
Q4 24
$0.17
Q3 24
$0.17
Q2 24
$0.15
Q1 24
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
HTBK
HTBK
Cash + ST InvestmentsLiquidity on hand
$90.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$341.7M
$708.6M
Total Assets
$461.5M
$5.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
HTBK
HTBK
Q4 25
$90.9M
Q3 25
$93.3M
Q2 25
$75.5M
Q1 25
$95.3M
Q4 24
$98.7M
Q3 24
$162.3M
Q2 24
$177.9M
Q1 24
$168.8M
Stockholders' Equity
CTKB
CTKB
HTBK
HTBK
Q4 25
$341.7M
$708.6M
Q3 25
$378.6M
$700.0M
Q2 25
$377.6M
$694.7M
Q1 25
$379.6M
$696.2M
Q4 24
$395.7M
$689.7M
Q3 24
$385.5M
$685.4M
Q2 24
$389.1M
$679.2M
Q1 24
$392.6M
$676.3M
Total Assets
CTKB
CTKB
HTBK
HTBK
Q4 25
$461.5M
$5.8B
Q3 25
$494.9M
$5.6B
Q2 25
$493.3M
$5.5B
Q1 25
$482.6M
$5.5B
Q4 24
$499.5M
$5.6B
Q3 24
$491.2M
$5.6B
Q2 24
$483.7M
$5.3B
Q1 24
$492.1M
$5.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
HTBK
HTBK
Operating Cash FlowLast quarter
$-771.0K
$61.7M
Free Cash FlowOCF − Capex
$-1.8M
$61.3M
FCF MarginFCF / Revenue
-2.9%
114.3%
Capex IntensityCapex / Revenue
1.6%
0.7%
Cash ConversionOCF / Net Profit
4.08×
TTM Free Cash FlowTrailing 4 quarters
$-8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
HTBK
HTBK
Q4 25
$-771.0K
$61.7M
Q3 25
$-3.9M
$18.9M
Q2 25
$108.0K
$8.0M
Q1 25
$-125.0K
$14.8M
Q4 24
$2.0M
$39.0M
Q3 24
$13.2M
$5.3M
Q2 24
$6.2M
$10.5M
Q1 24
$4.0M
$7.3M
Free Cash Flow
CTKB
CTKB
HTBK
HTBK
Q4 25
$-1.8M
$61.3M
Q3 25
$-4.6M
$18.8M
Q2 25
$-1.5M
Q1 25
$-974.0K
Q4 24
$1.1M
$37.3M
Q3 24
$12.2M
$4.9M
Q2 24
$5.2M
$9.9M
Q1 24
$3.4M
$6.9M
FCF Margin
CTKB
CTKB
HTBK
HTBK
Q4 25
-2.9%
114.3%
Q3 25
-8.7%
37.7%
Q2 25
-3.2%
Q1 25
-2.3%
Q4 24
1.9%
80.5%
Q3 24
23.7%
11.6%
Q2 24
11.0%
23.6%
Q1 24
7.6%
16.4%
Capex Intensity
CTKB
CTKB
HTBK
HTBK
Q4 25
1.6%
0.7%
Q3 25
1.3%
0.1%
Q2 25
3.5%
Q1 25
2.0%
Q4 24
1.6%
3.5%
Q3 24
2.0%
1.0%
Q2 24
2.3%
1.6%
Q1 24
1.3%
1.0%
Cash Conversion
CTKB
CTKB
HTBK
HTBK
Q4 25
4.08×
Q3 25
1.28×
Q2 25
1.25×
Q1 25
1.28×
Q4 24
0.21×
3.67×
Q3 24
14.05×
0.50×
Q2 24
1.14×
Q1 24
0.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

HTBK
HTBK

Segment breakdown not available.

Related Comparisons